Literature DB >> 10077344

Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome.

P De Becker1, K De Meirleir, E Joos, I Campine, E Van Steenberge, J Smitz, B Velkeniers.   

Abstract

Previous studies have demonstrated concentrating neuroendocrinological disturbances in chronic fatigue syndrome (CFS) patients, concentrating in particular on low cortisol levels and a hypothalamic deficiency. In order to investigate the dynamic response of the adrenal glands, we measured dehydroepiandrosterone (DHEA) in serum after adreno-corticotropic hormone (ACTH) stimulation during 60 minutes in 22 CFS-patients and 14 healthy controls. We found normal basal DHEA levels, but a blunted serum DHEA response curve to i.v. ACTH injection. This observation adds to the large amount of evidence of endocrinological abnormalities in CFS. Relative glucocorticoid deficiency might contribute to the overall clinical picture in CFS, and could explain some of the immunological disturbances observed in this syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077344     DOI: 10.1055/s-2007-978690

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

Review 1.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

Review 2.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Dominic Stanculescu; Lars Larsson; Jonas Bergquist
Journal:  Front Med (Lausanne)       Date:  2021-01-28

4.  Perspective: Drawing on Findings From Critical Illness to Explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Dominic Stanculescu; Jonas Bergquist
Journal:  Front Med (Lausanne)       Date:  2022-03-08

5.  The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.

Authors:  Tayfun Turan; Hasan Basri Izgi; Saliha Ozsoy; Fatih Tanrıverdi; Mustafa Basturk; Akif Asdemir; Aslı Beşirli; Ertugrul Esel; Seher Sofuoglu
Journal:  Psychiatry Investig       Date:  2009-06-23       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.